The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal ...
In the fight against COVID-19, two FDA-approved mRNA vaccines were developed by Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273), which produce the SARS-CoV-2 spike protein to activate potent B and ...
January 2025 marks five years since the beginning of the COVID-19 pandemic that resulted in 1,216,305 American deaths and ...
The vast majority of people in a study with long COVID had experienced multiple SARS-CoV-2 infections over the course of a ...
Newly developed vaccine could protect against emerging SARS-CoV-2 variants and related coronaviruses that may jump from ...
A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.
“Taken together, these results indicate that, once PNP or NNP patients develop neuro-PASC, whether they contracted SARS-CoV-2 infection prior to, or after SARS-CoV-2 vaccination makes little ...
In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback